“…Recently, EBC has been used in monitoring gastrointestinal diseases, such as gastroesophageal reflux disease (91,81,39,58), inflammatory bowel disease (56,52,44), coeliac disease (5,43). Other studies were carried out to monitor systemic sclerosis (28,93), liver diseases (6), abdominal surgery (66,84,65), obese population (13), impacts of oxidative stress (78,94,63) or for toxicity screening (34,79,57).…”